Trangil, Erha T.
HRN: 22-11-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2022
CEFTAZIDIME 1GM (VIAL)
10/28/2022
11/04/2022
IV
200mg
Q8h
Burns
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes